Thyroid-stimulating hormone (TSH) is elevated.

When thyroid-stimulating hormone (TSH) levels are elevated, it typically indicates that the thyroid gland is not producing sufficient thyroid hormones—a condition known as primary hypothyroidism. TSH is secreted by the anterior pituitary gland in response to low circulating levels of thyroxine (T4) and triiodothyronine (T3). As a feedback mechanism, reduced thyroid hormone output triggers increased TSH secretion in an attempt to stimulate thyroid activity.

Elevated TSH may be detected incidentally during routine blood testing or in the context of symptoms such as fatigue, weight gain, cold intolerance, dry skin, constipation, slowed cognition, or depression. However, some individuals—particularly those with subclinical hypothyroidism—may have mildly elevated TSH with normal free T4 levels and minimal or no symptoms.

Common causes include autoimmune thyroiditis (e.g., Hashimoto’s thyroiditis), prior radioactive iodine therapy or thyroid surgery, iodine deficiency (less common in iodine-sufficient regions), certain medications (e.g., lithium, amiodarone), and recovery from non-thyroidal illness. Rarely, elevated TSH can stem from a TSH-secreting pituitary adenoma or assay interference—though these are uncommon and usually accompanied by elevated free T4/T3 levels (i.e., central hyperthyroidism or factitious results).

Diagnostic evaluation should include measurement of serum free T4 and, when clinically indicated, thyroid peroxidase (TPO) antibodies. A persistently elevated TSH with low or low-normal free T4 confirms overt hypothyroidism and generally warrants levothyroxine replacement therapy. Management decisions for subclinical cases depend on TSH magnitude, symptom burden, antibody status, pregnancy plans, and comorbidities—and should be individualized in consultation with an endocrinologist or qualified healthcare provider.